Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1946 1
1947 4
1948 1
1949 1
1950 3
1952 1
1954 2
1958 1
1959 2
1960 1
1963 2
1965 2
1967 1
1968 1
1969 1
1970 2
1972 1
1973 4
1974 5
1975 9
1976 8
1977 9
1978 4
1979 5
1980 9
1981 6
1982 4
1983 11
1984 7
1985 7
1986 9
1987 8
1988 4
1989 8
1990 12
1991 12
1992 14
1993 13
1994 19
1995 19
1996 23
1997 15
1998 20
1999 16
2000 28
2001 37
2002 33
2003 28
2004 36
2005 42
2006 40
2007 43
2008 42
2009 39
2010 48
2011 74
2012 38
2013 48
2014 35
2015 39
2016 37
2017 50
2018 45
2019 46
2020 54
2021 56
2022 58
2023 53
2024 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,293 results

Results by year

Filters applied: . Clear all
Page 1
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL. Swanson CJ, et al. Among authors: kramer ld. Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8. Alzheimers Res Ther. 2021. PMID: 33865446 Free PMC article. Clinical Trial.
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
McDade E, Cummings JL, Dhadda S, Swanson CJ, Reyderman L, Kanekiyo M, Koyama A, Irizarry M, Kramer LD, Bateman RJ. McDade E, et al. Among authors: kramer ld. Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2. Alzheimers Res Ther. 2022. PMID: 36544184 Free PMC article. Clinical Trial.
A compendium of genetic regulatory effects across pig tissues.
Teng J, Gao Y, Yin H, Bai Z, Liu S, Zeng H; PigGTEx Consortium; Bai L, Cai Z, Zhao B, Li X, Xu Z, Lin Q, Pan Z, Yang W, Yu X, Guan D, Hou Y, Keel BN, Rohrer GA, Lindholm-Perry AK, Oliver WT, Ballester M, Crespo-Piazuelo D, Quintanilla R, Canela-Xandri O, Rawlik K, Xia C, Yao Y, Zhao Q, Yao W, Yang L, Li H, Zhang H, Liao W, Chen T, Karlskov-Mortensen P, Fredholm M, Amills M, Clop A, Giuffra E, Wu J, Cai X, Diao S, Pan X, Wei C, Li J, Cheng H, Wang S, Su G, Sahana G, Lund MS, Dekkers JCM, Kramer L, Tuggle CK, Corbett R, Groenen MAM, Madsen O, Gòdia M, Rocha D, Charles M, Li CJ, Pausch H, Hu X, Frantz L, Luo Y, Lin L, Zhou Z, Zhang Z, Chen Z, Cui L, Xiang R, Shen X, Li P, Huang R, Tang G, Li M, Zhao Y, Yi G, Tang Z, Jiang J, Zhao F, Yuan X, Liu X, Chen Y, Xu X, Zhao S, Zhao P, Haley C, Zhou H, Wang Q, Pan Y, Ding X, Ma L, Li J, Navarro P, Zhang Q, Li B, Tenesa A, Li K, Liu GE, Zhang Z, Fang L. Teng J, et al. Among authors: kramer l. Nat Genet. 2024 Jan;56(1):112-123. doi: 10.1038/s41588-023-01585-7. Epub 2024 Jan 4. Nat Genet. 2024. PMID: 38177344 Free PMC article.
The roots of infectious disease science.
Lee SS, Blumberg L, Kramer L, Al-Abri S, Obiero C, Pinto TCA, Yapi R, Abubakar AA, Petersen E. Lee SS, et al. Among authors: kramer l. IJID Reg. 2021 Dec 21;1:170-171. doi: 10.1016/j.ijregi.2021.12.004. eCollection 2021 Dec. IJID Reg. 2021. PMID: 35757830 Free PMC article. No abstract available.
Acute liver failure.
Kramer L. Kramer L. Wien Klin Wochenschr. 2004 Feb 16;116(3):67-81. doi: 10.1007/BF03040699. Wien Klin Wochenschr. 2004. PMID: 15008314 Review.
Evolution-Guided Biosynthesis of Terpenoid Inhibitors.
Sarkar A, Foderaro T, Kramer L, Markley AL, Lee J, Traylor MJ, Fox JM. Sarkar A, et al. Among authors: kramer l. ACS Synth Biol. 2022 Sep 16;11(9):3015-3027. doi: 10.1021/acssynbio.2c00188. Epub 2022 Aug 19. ACS Synth Biol. 2022. PMID: 35984356
Predicting clinical progression trajectories of early Alzheimer's disease patients.
Devanarayan V, Ye Y, Charil A, Andreozzi E, Sachdev P, Llano DA, Tian L, Zhu L, Hampel H, Kramer L, Dhadda S, Irizarry M; Alzheimer's Disease Neuroimaging Initiative (ADNI). Devanarayan V, et al. Among authors: kramer l. Alzheimers Dement. 2024 Mar;20(3):1725-1738. doi: 10.1002/alz.13565. Epub 2023 Dec 13. Alzheimers Dement. 2024. PMID: 38087949 Free PMC article.
1,293 results